A new method for analyzing protein crystals – developed by Cornell researchers and given a funky two-part name – could open up applications for new drug discovery and other areas of biotechnology and biochemistry.
Bits On Our Minds technology showcase, held April 27 in the Duffield Hall atrium, featured cutting-edge technology projects from across the university.
Patients with HIV had similar treatment outcomes to patients without HIV when treated for mpox with an antiviral drug called tecovirimat, according to a new study.
As part of a new cross-college initiative designed to accelerate engineering innovations in medicine, Cornell Engineering is piloting an M.D.-M.Eng. program that allows medical students at Weill Cornell Medicine to earn a one-year professional Master of Engineering degree.
The Big Red was awash in tie-dye May 8 as Dead & Company came to Barton Hall for a jubilant benefit show that had multiple generations celebrating the return of members of the Grateful Dead to the site of one of their most historic shows.
An enthusiastic audience of 100 Cornellians celebrated academic achievements and community at the Office of Academic Diversity Initiatives’ annual Honors Award Ceremony on May 5.
Cutting-edge, data-driven agricultural technologies and precision management strategies designed for the farm of the future will be developed, evaluated and demonstrated, thanks to a four-year, $4.3 million U.S. Department of Agriculture grant.
Nearly 90% of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
Two Cornell faculty members have been named Freeman Hrabowski Scholars by the Howard Hughes Medical Institute, in recognition of their potential to become leaders in their research fields and to create diverse and inclusive lab environments.